Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03175549 · ClinicalTrials.gov registry record · Phase 2

Medication Development in Alcoholism: Apremilast Versus Placebo

A Phase 2 study of Alcohol Use Disorder, sponsored by The Scripps Research Institute.

Completed
Registry status
Phase 2
Development phase
51
Enrollment target
1
Study location

NCT03175549 is a Phase 2 study of Alcohol Use Disorder that has completed, run by The Scripps Research Institute. The registered enrollment target is 51 participants, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03175549, a Phase 2 study of Alcohol Use Disorder, has completed, sponsored by The Scripps Research Institute.

COMPLETED
Registry status
Phase 2
Development phase
51 participants
Enrollment target
1
Study location

Study Summary

The primary hypotheses under test are that alcohol dependent subjects treated with apremilast will report decreased craving for alcohol following alcohol exposure in the laboratory and report significantly less drinking under naturalistic conditions, than those treated with placebo.

Conditions Studied

Alcohol Use Disorder

Interventions

  • DRUG Placebo
  • DRUG Apremilast

Study Locations (1)

California

  • The Scripps Research Institute Pearson Center for Alcoholism and Addiction Research - La Jolla

Trial Details

FieldValue
Enrollment Target 51 participants
Start Date 2017-11-01
Est. Completion 2020-04-01
Phase Phase 2

Sponsor

The Scripps Research Institute

16 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03175549

The ClinicalTrials.gov registry entry for NCT03175549 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (84% lower). The listed sponsor is The Scripps Research Institute, which has 16 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Alcohol Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT03175549 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03175549 about?

NCT03175549 is a clinical study titled "Medication Development in Alcoholism: Apremilast Versus Placebo". The primary hypotheses under test are that alcohol dependent subjects treated with apremilast will report decreased craving for alcohol following alcohol exposure in the laboratory and report significantly less drinking under naturalistic conditions, than those treated with placebo.

What is the current status of trial NCT03175549?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 51 participants. The study started on 2017-11-01. Estimated completion is 2020-04-01.

What conditions does trial NCT03175549 study?

This clinical trial studies the following conditions: Alcohol Use Disorder.

What interventions are being tested in trial NCT03175549?

The interventions under investigation include: Placebo (DRUG), Apremilast (DRUG).

Who is sponsoring clinical trial NCT03175549?

This trial is sponsored by The Scripps Research Institute, which has 16 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03175549 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Alcohol Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Alcohol Use Disorder

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.